F. Geurs
Impact in
- Oncology top 5%
- Bone health and treatments
- Cancer Diagnosis and Treatment
- Peptidase Inhibition and Analysis
-
- Bone health and osteoporosis research
- Bone and Joint Diseases
Papers in
- Oncology 7
- Colorectal Cancer Treatments and Studies 3
- Cancer Treatment and Pharmacology 2
-
- Gastric Cancer Management and Outcomes 3
- Co-authors
- Thierry Façon (2 shared papers)Allan Lipton (2 shared papers)Robert E. Coleman (2 shared papers)Pirow Bekker (2 shared papers)Donna Holloway (2 shared papers)Mark Peterson (1 shared paper)Jean-Jacques Body (1 shared paper)Michelle Fan (1 shared paper)
- Journals
- Clinical Cancer Research (1 paper)Critical Reviews in Oncology/Hematology (1 paper)Supportive Care in Cancer (1 paper)Age and Ageing (1 paper)Cancer (1 paper)
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
F. Geurs
10 papers receiving 646 citations
Peers
Comparison fields: 5 of 45
- Oncology 513
- Orthopedics and Sports Medicine 124
- Hematology 116
- Radiology, Nuclear Medicine and Imaging 139
- Rheumatology 62
Countries citing papers authored by F. Geurs
This map shows the geographic impact of F. Geurs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Geurs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Geurs more than expected).
Fields of papers citing papers by F. Geurs
This network shows the impact of papers produced by F. Geurs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Geurs. The network helps show where F. Geurs may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Geurs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 348 | |
| 2 | 2003 | 295 | |
| 3 | 1997 | 10 | |
| 4 | 1997 | 6 | |
| 5 | 2009 | 6 | |
| 6 | 2008 | 2 | |
| 7 | 2012 | 2 | |
| 8 | 2011 | 2 | |
| 9 | Phase I clinical study of Docetaxel (TXT) in combination with continuous infusion (CI) Fluorouracil (5-FU) in patients (pts) with advanced solid tumors | 1996 | 1 |
| 10 | 2006 | 1 | |
| 11 | 2010 | 0 |
About F. Geurs
F. Geurs is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Hematology and Molecular Biology, having authored 11 papers that have together received 673 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (2 papers), Acute Myeloid Leukemia Research (1 paper), Diabetes and associated disorders (1 paper), Bone Metabolism and Diseases (1 paper), Blood groups and transfusion (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Oncology (513 citations), Orthopedics and Sports Medicine (124 citations), Hematology (116 citations), Radiology, Nuclear Medicine and Imaging (139 citations) and Rheumatology (62 citations). F. Geurs has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Thierry Façon, Allan Lipton, Robert E. Coleman, Pirow Bekker, Donna Holloway, Mark Peterson, Jean-Jacques Body, Michelle Fan, Catherine Williams and Arline Nakanishi. Their work appears in journals such as Clinical Cancer Research, Critical Reviews in Oncology/Hematology, Supportive Care in Cancer, Age and Ageing and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.